177 related articles for article (PubMed ID: 10080952)
41. Mitocryptide-2: purification, identification, and characterization of a novel cryptide that activates neutrophils.
Mukai H; Seki T; Nakano H; Hokari Y; Takao T; Kawanami M; Tsukagoshi H; Kimura H; Kiso Y; Shimonishi Y; Nishi Y; Munekata E
J Immunol; 2009 Apr; 182(8):5072-80. PubMed ID: 19342687
[TBL] [Abstract][Full Text] [Related]
42. Chemoattractant properties of PR-39, a neutrophil antibacterial peptide.
Huang HJ; Ross CR; Blecha F
J Leukoc Biol; 1997 May; 61(5):624-9. PubMed ID: 9129212
[TBL] [Abstract][Full Text] [Related]
43. Heparin modulates migration of human peripheral blood mononuclear cells and neutrophils.
Zak-Nejmark T; Krasnowska M; Jankowska R; Jutel M
Arch Immunol Ther Exp (Warsz); 1999; 47(4):245-9. PubMed ID: 10483873
[TBL] [Abstract][Full Text] [Related]
44. Inhibitory effect of (-)-epigallocatechin 3-gallate, a polyphenol of green tea, on neutrophil chemotaxis in vitro and in vivo.
Takano K; Nakaima K; Nitta M; Shibata F; Nakagawa H
J Agric Food Chem; 2004 Jul; 52(14):4571-6. PubMed ID: 15237969
[TBL] [Abstract][Full Text] [Related]
45. Immobilized chemoattractant peptides mediate adhesion and distinct calcium-dependent cell signaling in human neutrophils.
Wetterö J; Hellerstedt T; Nygren P; Broo K; Aili D; Liedberg B; Magnusson KE
Langmuir; 2008 Jun; 24(13):6803-11. PubMed ID: 18507416
[TBL] [Abstract][Full Text] [Related]
46. Characterization of leukocyte-derived neutrophil chemotactic factor-2 and its possible roles in neutrophil infiltration in allergic inflammation in rats.
Tanabe J; Watanabe M; Fujimoto N; Mue S; Ohuchi K
Int Arch Allergy Immunol; 1995 Oct; 108(2):148-57. PubMed ID: 7549502
[TBL] [Abstract][Full Text] [Related]
47. NH2- and COOH-terminal truncations of murine granulocyte chemotactic protein-2 augment the in vitro and in vivo neutrophil chemotactic potency.
Wuyts A; D'Haese A; Cremers V; Menten P; Lenaerts JP; De Loof A; Heremans H; Proost P; Van Damme J
J Immunol; 1999 Dec; 163(11):6155-63. PubMed ID: 10570306
[TBL] [Abstract][Full Text] [Related]
48. The heparin III-binding domain of fibronectin (III4-5 repeats) binds to fibronectin and inhibits fibronectin matrix assembly.
Maqueda A; Moyano JV; Hernández Del Cerro M; Peters DM; Garcia-Pardo A
Matrix Biol; 2007 Oct; 26(8):642-51. PubMed ID: 17611093
[TBL] [Abstract][Full Text] [Related]
49. Latent fibronectin-degrading serine proteinase activity in N-terminal heparin-binding domain of human plasma fibronectin.
Lambert Vidmar S; Lottspeich F; Emod I; Planchenault T; Keil-Dlouha V
Eur J Biochem; 1991 Oct; 201(1):71-7. PubMed ID: 1915379
[TBL] [Abstract][Full Text] [Related]
50. Study on preparation and activity of a novel recombinant human parathyroid hormone(1-34) analog with N-terminal Pro-Pro extension.
Chunxiao W; Jingjing L; Yire X; Min D; Zhaohui W; Gaofu Q; Xiangchun S; Xuejun W; Jie W; Taiming L
Regul Pept; 2007 Jun; 141(1-3):35-43. PubMed ID: 17300845
[TBL] [Abstract][Full Text] [Related]
51. Identification of a novel platelet-derived neutrophil-chemotactic polypeptide with structural homology to platelet-factor 4.
Schröder JM; Sticherling M; Persoon NL; Christophers E
Biochem Biophys Res Commun; 1990 Oct; 172(2):898-904. PubMed ID: 2241978
[TBL] [Abstract][Full Text] [Related]
52. Bioactivity of peptide analogs of the neutrophil chemoattractant, N-acetyl-proline-glycine-proline.
Haddox JL; Pfister RR; Muccio DD; Villain M; Sommers CI; Chaddha M; Anantharamaiah GM; Brouillette WJ; DeLucas LJ
Invest Ophthalmol Vis Sci; 1999 Sep; 40(10):2427-9. PubMed ID: 10476813
[TBL] [Abstract][Full Text] [Related]
53. Purification and characterization of native type XIV collagen.
Aubert-Foucher E; Font B; Eichenberger D; Goldschmidt D; Lethias C; van der Rest M
J Biol Chem; 1992 Aug; 267(22):15759-64. PubMed ID: 1322405
[TBL] [Abstract][Full Text] [Related]
54. Identification of the heparin-binding region of snake venom vascular endothelial growth factor (VEGF-F) and its blocking of VEGF-A165.
Yamazaki Y; Tokunaga Y; Takani K; Morita T
Biochemistry; 2005 Jun; 44(24):8858-64. PubMed ID: 15952792
[TBL] [Abstract][Full Text] [Related]
55. Isolation and purification of neutrophil-activating peptide-4: a chemokine missing two cysteines.
Schröder JM
Methods Enzymol; 1997; 287():216-30. PubMed ID: 9330325
[No Abstract] [Full Text] [Related]
56. Structural requirements for the activity of an immunologically generated lipid chemotactic factor.
Valone FH; Goetzl EJ
Immunology; 1980 Nov; 41(3):517-24. PubMed ID: 6780447
[TBL] [Abstract][Full Text] [Related]
57. Specificities of heparin-binding sites from the amino-terminus and type 1 repeats of thrombospondin-1.
Yu H; Tyrrell D; Cashel J; Guo NH; Vogel T; Sipes JM; Lam L; Fillit HM; Hartman J; Mendelovitz S; Panel A; Roberts DD
Arch Biochem Biophys; 2000 Feb; 374(1):13-23. PubMed ID: 10640391
[TBL] [Abstract][Full Text] [Related]
58. Peptides of type II collagen can induce the cleavage of type II collagen and aggrecan in articular cartilage.
Yasuda T; Tchetina E; Ohsawa K; Roughley PJ; Wu W; Mousa A; Ionescu M; Pidoux I; Poole AR
Matrix Biol; 2006 Sep; 25(7):419-29. PubMed ID: 16919430
[TBL] [Abstract][Full Text] [Related]
59. Characterization of natural vasostatin-containing peptides in rat heart.
Glattard E; Angelone T; Strub JM; Corti A; Aunis D; Tota B; Metz-Boutigue MH; Goumon Y
FEBS J; 2006 Jul; 273(14):3311-21. PubMed ID: 16857014
[TBL] [Abstract][Full Text] [Related]
60. Primary structure of a DNA- and heparin-binding domain (Domain III) in human plasma fibronectin.
Calaycay J; Pande H; Lee T; Borsi L; Siri A; Shively JE; Zardi L
J Biol Chem; 1985 Oct; 260(22):12136-41. PubMed ID: 3900070
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
